190 related articles for article (PubMed ID: 19506822)
1. Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.
Cambria R; Jereczek-Fossa BA; Cattani F; Garibaldi C; Zerini D; Fodor C; Serafini F; Pedroli G; Orecchia R
Strahlenther Onkol; 2009 Jun; 185(6):384-9. PubMed ID: 19506822
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
3. Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis.
Troeller A; Yan D; Marina O; Schulze D; Alber M; Parodi K; Belka C; Söhn M
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):435-43. PubMed ID: 25636766
[TBL] [Abstract][Full Text] [Related]
4. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
5. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
[TBL] [Abstract][Full Text] [Related]
6. Rectal complication probability from composite volumes derived from daily cone beam computed tomography in prostate cancer radiotherapy.
Prabhakar R; Oates R; Daryl J; Chang J; Geso M; Cramb J
J Cancer Res Ther; 2016; 12(1):374-8. PubMed ID: 27072266
[TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
García-Vicente F; Zapatero A; Floriano A; Cruz-Conde A; Perez L; Marín A; Mínguez C; Torres JJ
Med Phys; 2005 Aug; 32(8):2503-9. PubMed ID: 16193780
[TBL] [Abstract][Full Text] [Related]
8. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
9. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
10. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
11. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
12. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
[TBL] [Abstract][Full Text] [Related]
13. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
Koelbl O; Richter S; Flentje M
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
[TBL] [Abstract][Full Text] [Related]
14. Estimation of α/β for late rectal toxicity based on RTOG 94-06.
Tucker SL; Thames HD; Michalski JM; Bosch WR; Mohan R; Winter K; Cox JD; Purdy JA; Dong L
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):600-5. PubMed ID: 21377288
[TBL] [Abstract][Full Text] [Related]
15. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
16. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.
Greco C; Mazzetta C; Cattani F; Tosi G; Castiglioni S; Fodor A; Orecchia R
Radiother Oncol; 2003 Nov; 69(2):215-22. PubMed ID: 14643961
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
18. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.
Dale E; Olsen DR; Fosså SD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):385-91. PubMed ID: 10030266
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
[TBL] [Abstract][Full Text] [Related]
20. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.
Söhn M; Yan D; Liang J; Meldolesi E; Vargas C; Alber M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1066-73. PubMed ID: 17258870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
